Live from the NIH registry
Studies recruiting near Cedar Rapids right now
Top 25 of 584 recruiting studies, sorted by proximity — each links to its official registry page
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Iowa City, Iowa (22.4 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
Palbociclib and Pembrolizumab in Sarcoma
Sarcoma
Phase 1
Interventional 8 participants sought
University of Iowa Hospitals & Clinics — Iowa City, Iowa (22.4 mi)
· Sponsor: John Rieth
Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
Rheumatoid Arthritis, Sjogren's Syndrome
N/A
Interventional 400 participants sought
Univeristy of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: Terry L. Wahls
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: C4 Therapeutics, Inc.
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Advanced Renal Cell Carcinoma (RCC)
Phase 1, Phase 2
Interventional 474 participants sought
University Of Iowa Hospitals And Clinics — Iowa City, Iowa (22.4 mi)
· Sponsor: Bristol-Myers Squibb
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Phase 2
Interventional 113 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: Anagram Therapeutics, Inc.
Glaucoma Related Quality of Life
Glaucoma
N/A
Observational 5,000 participants sought
University of Iowa, Dept. of Ophthalmology & Visual Sciences — Iowa City, Iowa (22.4 mi)
· Sponsor: Marc Toeteberg-Harms
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Physicians' Clinic of Iowa PC — Cedar Rapids, Iowa (3.4 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
Limb Girdle Muscular Dystrophy, Limb-Girdle Muscular Dystrophy Type 2
Phase 1, Phase 2
Interventional 10 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: AskBio Inc
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma
Phase 1
Interventional 65 participants sought
University of Iowa/Holden Comprehensive Cancer Center — Iowa City, Iowa (22.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50319 — Iowa City, Iowa (22.4 mi)
· Sponsor: UCB Biopharma SRL
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Phase 3
Interventional 600 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: Hoffmann-La Roche
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: Jaeb Center for Health Research
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Prostate Cancer
Phase 3
Interventional 940 participants sought
Univ Of Iowa Hospitals And Clinics — Iowa City, Iowa (22.4 mi)
· Sponsor: Novartis Pharmaceuticals
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Iowa City, Iowa (22.4 mi)
· Sponsor: Sameek Roychowdhury
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
Colo-rectal Cancer
Phase 2
Interventional 79 participants sought
University of Iowa - Holden Comprehensive Cancer Center — Iowa City, Iowa (22.4 mi)
· Sponsor: NSABP Foundation Inc
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Bladder Cancer, Recurrent Bladder Cancer
N/A
Observational 408 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: University of Washington
Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response
Breast Neoplasm Female
Phase 4
Interventional 50 participants sought
University of Iowa Health Care/Holden Comprehensive Cancer Center — Iowa City, Iowa (22.4 mi)
· Sponsor: University of Wisconsin, Madison
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Spinal Muscular Atrophy (SMA)
N/A
Observational 700 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: Novartis Pharmaceuticals
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
Phase 3
Interventional 136 participants sought
University of Iowa Hospitals & Clinics- Holden Comprehensive Cancer Center — Iowa City, Iowa (22.4 mi)
· Sponsor: Servier Bio-Innovation LLC
Dime La VerDAD: Verify, Debunk, and Disseminate
Influenza, COVID-19
N/A
Interventional 1,400 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: University of Chicago
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: Kura Oncology, Inc.
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
University of Iowa — Iowa City, Iowa (22.4 mi)
· Sponsor: Lyell Immunopharma, Inc.
The Pediatric Anesthesia Quality Improvement Project
Surgery, Anesthesia
N/A
Observational 5,000,000 participants sought
University of Iowa Stead Family Children's Hospital — Iowa City, Iowa (22.4 mi)
· Sponsor: The Society for Pediatric Anesthesia
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
University of Iowa/Holden Comprehensive Cancer Center — Iowa City, Iowa (22.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group